The pandemic (H1N1) 2009 influenza virus is resistant to mannose-binding lectin

11Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Mannose-binding lectin (MBL) is an important component of innate immunity because it promotes bacterial clearance and neutralization of human influenza A viruses. Since a majority of humans have no neutralizing antibody against the pandemic (H1N1) 2009 influenza (pandemic 2009) virus, innate immunity may be crucial and MBL susceptibility may therefore influence viral pathogenesis. Results: We examined MBL susceptibility of influenza A viruses and observed that the pandemic 2009 virus was resistant to MBL, whereas all seasonal influenza A viruses tested were susceptible. The mortality of mice infected with a seasonal H1N1 influenza virus was evidently enhanced on transient blockage of MBL activity by simultaneous inoculation of mannan, whereas mannan inoculation had no effect on mice infected with a pandemic 2009 virus. This indicates that MBL protects mice against infection with the seasonal virus but not against that with the pandemic 2009 virus. Conclusions: These results indicate that the pandemic 2009 virus is not susceptible to MBL, an important component of innate immunity. © 2011 Tokunaga et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Tokunaga, H., Ushirogawa, H., & Ohuchi, M. (2011). The pandemic (H1N1) 2009 influenza virus is resistant to mannose-binding lectin. Virology Journal, 8. https://doi.org/10.1186/1743-422X-8-50

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free